GNTA Stock Analysis: Buy, Sell, or Hold?
GNTA - Genenta Science S.p.A. American Depositary Shares
$1.30
-0.01 (-0.76%)
▼
5d:
-12.75%
30d:
-18.24%
90d:
+103.06%
HOLD
MODERATE Confidence
Analysis Updated: Aug 7, 2026 12:00 AM ET
Earnings: Mar 27, 2026
0d
Get Alerted When GNTA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: GNTA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: GNTA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: GNTA is currently trading at $1.30, which is considered oversold relative to its 30-day fair value range of $1.36 to $1.65.
Technical Outlook: Technically, GNTA is in a strong uptrend. Immediate support is located at $1.20, while resistance sits at $1.69.
Market Sentiment: The stock scores a mixed 52/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $6.98 (+436.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, GNTA is in a strong uptrend. Immediate support is located at $1.20, while resistance sits at $1.69.
Market Sentiment: The stock scores a mixed 52/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $6.98 (+436.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.36 -
$1.65
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (52/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 436.9% below Wall St target ($6.98)
- NEUTRAL: Bottoming setup forming (52/100) — watch for confirmation
- CAUTION: 5-day price weakness (-12.8%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$1.36 -
$1.65
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.20
Resistance Level
$1.69
Current Trend
Strong Uptrend
Technical data as of
Aug 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.45
Wall Street Target
$6.98
(+436.9%)
Share & Embed Analysis
Last updated: August 09, 2026 3:29 AM ET
Data refreshes hourly during market hours. Next update: 4:29 AM
Data refreshes hourly during market hours. Next update: 4:29 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GNTA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 64 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$89 | 64 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 49 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 50 HOLD |
